Response by Henriksen et al Regarding Article, “Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial”
Circulation · 2024
DOI: 10.1161/circulationaha.124.069375 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Peter A Henriksen und 2 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Centre for Cardiovascular Science (P.A.H.), University of Edinburgh, UK. Hauptthemen laut MEDLINE: Troponin I, Cardiotoxicity, Anthracyclines, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- British Heart Foundation Centre for Cardiovascular Science (P.A.H.), University of Edinburgh, UK.
- Cancer Research UK - Edinburgh Centre (P.H.), University of Edinburgh, UK.
- Medical Research Council Institute Genetics and Molecular Medicine (P.H.), University of Edinburgh, UK.
- School of Cardiovascular and Metabolic Health, University of Glasgow, UK (N.N.L.).
ORCID-Profile: Peter A Henriksen, Peter Hall, Ninian N Lang
Zitieren
APA
Henriksen, P. A., Hall, P., & Lang, N. N. (2024). Response by Henriksen et al Regarding Article, “Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial”. Circulation. https://doi.org/10.1161/circulationaha.124.069375
Vancouver
Henriksen PA, Hall P, Lang NN. Response by Henriksen et al Regarding Article, “Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial”. Circulation. 2024. doi:10.1161/circulationaha.124.069375
BibTeX
@article{Henriksen2024,
author = {Henriksen, Peter A and Hall, Peter and Lang, Ninian N},
title = {Response by Henriksen et al Regarding Article, “Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial”},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.124.069375}
}
EUVIMED